Pagano C, Rossato M, Vettor R
Endocrine-Metabolic Laboratory, Clinica Medica 3, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy.
J Neuroendocrinol. 2008 May;20 Suppl 1:124-9. doi: 10.1111/j.1365-2826.2008.01690.x.
Endocannabinoids regulate energy balance by modulating hypothalamic circuits controlling food intake and energy expenditure. However, convincing evidence has accumulated indicating that the endocannabinoid system is present also in peripheral tissues, in particular in adipose tissue. Fat cells produce (and are targets of) endocannabinoids. Adipogenesis, lipogenesis and glucose uptake are stimulated by endocannabinoids through CB(1) receptors and these effects are blocked by the CB(1) receptor antagonist rimonabant, suggesting that the weight-lowering effect of CB(1) receptor blockade is partly due to peripheral mechanisms. This review will focus on the role of endocannabinoids in adipose tissue metabolism, adipokine production and interactions between endocannabinoids and peroxisome proliferator activated receptors during adipogenesis.
内源性大麻素通过调节下丘脑控制食物摄入和能量消耗的神经回路来调节能量平衡。然而,越来越多的确凿证据表明,内源性大麻素系统也存在于外周组织中,尤其是脂肪组织。脂肪细胞产生内源性大麻素(并且是其作用靶点)。内源性大麻素通过CB(1)受体刺激脂肪生成、脂质生成和葡萄糖摄取,而这些作用可被CB(1)受体拮抗剂利莫那班阻断,这表明阻断CB(1)受体的减肥作用部分归因于外周机制。本综述将重点关注内源性大麻素在脂肪组织代谢、脂肪因子产生以及脂肪生成过程中内源性大麻素与过氧化物酶体增殖物激活受体之间相互作用中的作用。